ÌÇÐÄvlog´«Ã½

Peripheral Stent Market Analysis

The peripheral stent market is expected to grow at a registered CAGR of 5.5% during the forecast period.

During the pandemic, the number of surgical procedures for peripheral arterial disease (PAD) patients got restricted, and the willingness to seek medical treatment also changed. The number of patients with PAD who underwent surgery was significantly reduced, but the severity of their limb ischemia was significantly higher than the previous year, resulting in a higher rate of perioperative complications. According to an article published by PubMed Central in August 2021, during the early pandemic, the reduced number of regular medical follow-ups and hindered hospital access resulted in more acute and advanced clinical presentations of patients with PAD undergoing surgery. Thus, the COVID-19 pandemic significantly impacted the market initially, however, as the pandemic has subsided, cardiological procedures are taking place normally. Hence the studied market is expected to have stable growth during the forecast period of the study.

The peripheral stent market is expected to grow due to the rise in the prevalence of peripheral diseases, the rise in the geriatric population, and the launch of advanced products. For instance, according to the CDC Report in September 2021, PAD affects both men and women, but African Americans are at a higher risk of developing it. When compared to non-Hispanic white people, Hispanics may have similar to slightly higher rates of PAD. PAD affects approximately 6.5 million people in the United States aged 40 and up. Thus, the rising prevalence of PAD is expected to increase the demand for peripheral stents, thereby boosting the market growth.

Additionally, the senior population, which is more prone to developing peripheral vascular diseases, is anticipated to drive the market growth. For instance, as per UN World Population Prospects 2022 data, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. Also it is estimated that by 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12.

Furthermore, market players use a variety of strategic initiatives to meet their growth goals and expand their market share. Key companies are launching new products, forming partnerships and collaborations, expanding their local and regional footprints, and pursuing mergers and acquisitions. For instance, in March 2022, Cordis, received FDA approval for its Smart Radianz Vascular Stent System, a self-expanding stent designed explicitly for radial peripheral procedures

The market may be in a position to grow, however, the stringent approval process for a stent may restrain it over the forecast period.

Peripheral Stent Market Trends

This section covers the major market trends shaping the Peripheral Stent Market according to our research experts:

The Renal and Related Stents Segment is Expected to Hold Significant Market Share Over the Forecast Period

Peripheral Stent Industry Segmentation

Per the scope of the report, peripheral stents are small tubular metal scaffolds that can be inserted in the peripheral vessels to treat narrowing or blockage within arteries or veins, resulting in improved blood flow. Peripheral stents are often implanted in conjunction with balloon angioplasty. 

The Peripheral Stent Market is segmented by Product (Bare Metal Stents (BMS), Covered Stents, Drug-Eluting Stents (DES)), Artery Type (Iliac Stents, Femoral-popliteal Stents, Renal and Related Stents, Carotid Stents), End-User (Hospitals, Ambulatory Surgical, Centers/Outpatientsand), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.